Results filtered:Study status:
Closed for Enrollment
An 8 week Randomized Double Blind Placebo Controlled Multi-site Study assessing Efficacy and Safety of MYDAYIS® (d-amphetamine / l-amphetamine) for Bipolar Depression
The purpose of this study is to assess the effectiveness and safety of MYDAYIS® as an augmentation agent for bipolar depression.
Randomized Controlled Trial of Stress Management and Resiliency Training for Depression (SMART-D) vs Treatment as Usual in the Treatment of Major Depression
Red Wing, Minn.,
Albert Lea, Minn.
The primary purpose of this study is to compare outcomes of depressive symptoms (PHQ-9 and HAM-D) over 6 months following an eight-week program of SMART-D therapy + treatment as usual versus treatment as usual for patients with major depression in partial-to full-remission.